Publications Library

Explore Sarepta’s library to find peer-reviewed publications by therapeutic area or program from 2018 onward.
The publications below are provided to support scientific exchange.
Publications may include information about investigational use(s) of compounds/products that are not approved for use by the U.S. Food and Drug Administration (FDA) and/or are inconsistent with the Prescribing Information. Sarepta does not recommend or suggest the use of any of its products beyond the approved Prescribing Information.

Questions?

Connect with one of our Medical Science Liaisons or submit a Medical Information Request
Search Sarepta’s Publications Library
Reset
Therapeutic Area
Study Type
Product/Program
Interested in Sarepta's Congress Presentations?
Access the Sarepta Congress Hub
Safety, Tolerability and Pharmacokinetics of Eteplirsen in Young Boys Aged 6 to 48 Months With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping
Authors: Mercuri E, Seferian AM, Servais L, Deconinck N, Stevenson H, Ni X, Zhang W, East L, Yonren S, Muntoni F, 4658-102 Study Group
Journal: Neuromuscular Disorders
Published: 01 June 2023
Assessing the Value of Delandistrogene Moxeparvovec (SRP-9001) Gene Transfer Therapy in Patients With Duchenne Muscular Dystrophy
Authors: Klimchak AC, Sedita LE, Rodino-Klapac LR, Mendell JR, McDonald CM, Gooch KL, Malone DC
Journal: Journal of Market Access & Health Policy
Published: 26 May 2023
Medicaid Coverage Practices for Approved Gene and Cell Therapies: Existing Barriers and Proposed Policy Solutions
Graphical Abstract
Authors: Allen J, Berry D, Cook F, Hume A, Rouce R, Srirangam A, Wellman J, McCombs C
Journal: Molecular Therapy Methods & Clinical Development
Published: 16 May 2023
Assessing the Impact of Single or Short-Term Administration on a Therapy’s Cost-Effectiveness: a Hypothetical Disease-Agnostic Model
Authors: Klimchak AC, Sedita LE, Gooch KL, Malone DC
Journal: Journal of Medical Economics
Published: 23 April 2023
Assessing the Impact of Single or Short-Term Administration on a Therapy's Cost-Effectiveness: a Hypothetical Disease-Agnostic Model
Authors: Klimchak AC, Sedita LE, Gooch KL, Malone DC
Journal: Journal of Medical Economics
Published: 23 April 2023
In-Cell Penetration Selection-Mass Spectrometry Produces Noncanonical Peptides for Antisense Delivery
Graphical Abstract
Authors: Schissel CK, Farquhar CE, Loas A, Malmberg AB, Pentelute BL
Journal: American Chemical Society (ACS) Chemical Biology
Published: 17 March 2023

Welcome to
Sarepta Medical

The resources contained within this website may include educational resources and information relating to medicines and therapeutic areas of interest, congress materials and publications.

This website is intended for U.S. healthcare professionals only. The content on the website is for personal, educational use only. No further reproduction or distribution is permitted without permission from copyright owner(s)

Please confirm below to continue:

I am NOT a US healthcare professional
Continue to
External URL